Janagliflozin Treat T2DM Monotherapy

NCT03811548 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

442

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Type 2

Interventions

DRUG: Janagliflozin 25mg
DRUG: Janagliflozin 50mg
DRUG: Placebo/Janagliflozin

Sponsor

Sihuan Pharmaceutical Holdings Group Ltd.